肌肽
肺动脉高压
缺氧(环境)
肺动脉
肠道菌群
内科学
缺氧性肺血管收缩
药理学
内分泌学
氧化应激
医学
肺血管系统
呼吸系统
生物
小动脉
右心室肥大
KEAP1型
粪便
抗氧化剂
代谢组
肺
化学
串扰
生理学
新陈代谢
泌尿系统
作者
Huaying Wei,Shikun Guo,Wenjing Ding,Yifan Yang,Xinyu Hu,Ailifeila Aili,Xiaolan Chen,Xinying Xue,Lei Pan
摘要
Exposure to chronic hypobaric hypoxia provokes marked alterations in the gut microbiota and its metabolome, yet the functional significance of histidine-derived metabolites in hypobaric hypoxic pulmonary hypertension (PH) remains underexplored. Here, we employ 16S rDNA, metagenomic, and untargeted metabolomic sequencing to characterize longitudinal shifts in the fecal microbiota and metabolites during hypobaric hypoxic PH development in Sprague-Dawley rats. Fecal carnosine levels and the abundance of its producer, Ruminococcus bromii, both decrease significantly over 28 days of hypobaric hypoxia (P < 0.05). Spearman correlation shows that carnosine is inversely correlated with the percentage of pulmonary arteriole media thickness (MT%; r = -0.8741, P < 0.001). Therapeutic supplementation with carnosine restores systemic and pulmonary antioxidant defenses and attenuates vascular remodeling without altering right ventricular pressures. In vitro, carnosine inhibits hypoxia‐induced pulmonary artery smooth muscle cell (PASMC) proliferation and migration and suppresses nuclear factor erythroid 2-related factor 2 (Nrf2) accumulation. These findings reveal dynamic gut-lung crosstalk in hypobaric hypoxic PH and nominate carnosine as a metabolite‐based intervention to mitigate hypoxia‐driven pulmonary vascular remodeling.
科研通智能强力驱动
Strongly Powered by AbleSci AI